Become a Research Partner with InSightec

ExAblate using non-invasive MR guided focused ultrasound technology has the potential to offer non-invasive treatment for a wide variety of applications as an alternative to invasive procedures. When you become a Research Partner with InSightec, you become an active participant in our progress toward non-invasive tumor ablation.

For more information, please contact us.

The ExAblate 2000 system integrates Magnetic Resonance Imaging (MRI) with focused ultrasound energy as a new treatment modality that can replace invasive procedures and provide therapeutic alternatives to millions of patients. Currently FDA approved to treat uterine fibroids, the company has launched an extensive research program to conduct clinical trials using this technology in other applications including breast, bone metastases, brain tumors and liver, while continuing clinical trials in uterine fibroids.

For more information on ExAblate 2000 applications and clinical trials using MR guided focused ultrasound, click on the following links:

Uterine Fibroids
Bone Metastases
Liver Tumors
Breast Cancer
Brain Tumors